Income Statement Harbin Gloria Pharmaceuticals Co., Ltd

Stocks

002437

CNE100000QG8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 2026-09-30			5-day change	1st Jan Change
3.650 ^CNY	+5.19%		+4.29%	+18.89%

08-26	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-27	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

a1286798c27b87f9626eb8.9ce5fzgnx008DlG_0jfofogitxFimQkkUB75v760p3E.x5frCwwX_yVRSGbGvFW3Td5jj2MY7jwcaUiwz93O4UO_sJRSTh6wJk0_Ng

Published financial data: HARBIN GLORIA PHARMACEUTICALS CO., LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Revenues	3.13B	3.1B	2.62B	2.44B	2.13B
Other Revenues, Total	14.07M	5.09M	7.02M	5.02M	4.38M
Total Revenues	3.15B	3.11B	2.63B	2.44B	2.14B
Cost of Goods Sold, Total	833M	743M	1.1B	1.14B	1.17B
Gross Profit	2.31B	2.37B	1.53B	1.3B	966M
Selling General & Admin Expenses, Total	2.06B	2.14B	1.24B	959M	628M
Provision for Bad Debts	-529K	-313K	-208K	-403K	101K
R&D Expenses	97.73M	101M	85.44M	90.79M	78.43M
Other Operating Expenses	41.17M	41.52M	29.2M	28.28M	28.97M
Other Operating Expenses, Total	2.2B	2.28B	1.36B	1.08B	736M
Operating Income	116M	85.61M	172M	225M	231M
Interest Expense, Total	-71.48M	-68.67M	-42.65M	-9.82M	-2.48M
Interest And Investment Income	17.21M	20.78M	18.47M	15.21M	142M
Net Interest Expenses	-54.27M	-47.89M	-24.18M	5.39M	139M
Currency Exchange Gains (Loss)	-3.86M	13.54M	1.19M	1.13M	-1.74M
Other Non Operating Income (Expenses)	-14.1M	-4.19M	-6.47M	814K	-409K
EBT, Excl. Unusual Items	43.44M	47.08M	143M	233M	368M
Impairment of Goodwill	-	-42.13M	-	-	-
Gain (Loss) On Sale Of Investments	-9.31M	-270M	-41.37M	-13.98M	5.98M
Gain (Loss) On Sale Of Assets	4.65M	3.82M	2.84M	3.4M	3.54M
Asset Writedown	-1.84M	-37.32M	-283K	-3.53M	-8.88M
Insurance Settlements	-	994K	2.02M	-	-
Other Unusual Items	49.03M	27.44M	71.06M	65.15M	41.22M
EBT, Incl. Unusual Items	85.97M	-270M	177M	284M	410M
Income Tax Expense	32.14M	19.84M	48.08M	41.15M	27.26M
Earnings From Continuing Operations	53.84M	-290M	129M	243M	382M
Net Income to Company	53.84M	-290M	129M	243M	382M
Minority Interest	-8.8M	-1.81M	-8.37M	-9.78M	-5.45M
Net Income - (IS)	45.04M	-291M	120M	233M	377M
Net Income to Common Incl Extra Items	45.04M	-291M	120M	233M	377M
Net Income to Common Excl. Extra Items	45.04M	-291M	120M	233M	377M
Per Share Items
Net EPS - Basic	0.02	-0.13	0.05	0.11	0.17
Basic EPS - Continuing Operations	0.02	-0.13	0.05	0.11	0.17
Basic Weighted Average Shares Outstanding	2.2B	2.2B	2.2B	2.2B	2.19B
Net EPS - Diluted	0.02	-0.13	0.05	0.1	0.17
Diluted EPS - Continuing Operations	0.02	-0.13	0.05	0.1	0.17
Diluted Weighted Average Shares Outstanding	2.2B	2.2B	2.2B	2.26B	2.24B
Normalized Basic EPS	0.01	0.01	0.04	0.06	0.1
Normalized Diluted EPS	0.01	0.01	0.04	0.06	0.1
Dividend Per Share	-	-	-	-	-
Payout Ratio	157.49	-23.6	36.41	4.02	0.32
Supplemental Items
EBITDA	253M	214M	276M	316M	320M
EBITA	155M	123M	201M	255M	264M
EBIT	116M	85.61M	172M	225M	231M
EBITDAR	256M	217M	278M	319M	323M
Total Revenues (As Reported)	3.15B	3.11B	2.63B	2.44B	2.14B
Effective Tax Rate - (Ratio)	37.38	-7.36	27.2	14.51	6.65
Total Current Taxes	27.56M	29.1M	36.07M	35.44M	27.42M
Total Deferred Taxes	4.57M	-9.26M	12.01M	5.71M	-160K
Normalized Net Income	18.36M	27.61M	80.7M	136M	224M
Interest on Long-Term Debt	-	-	-	-	163K
Non-Cash Pension Expense	1.53M	167K	11.88M	13.43M	4.99M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	1.41B	1.69B	881M	616M	350M
Selling and Marketing Expenses	1.82B	1.93B	1.07B	793M	496M
General and Administrative Expenses	241M	213M	175M	167M	132M
Research And Development Expense From Footnotes	120M	119M	91.25M	98.7M	100M
Net Rental Expense, Total	2.3M	2.3M	2.3M	3.38M	3.74M
Imputed Operating Lease Interest Expense	905K	839K	737K	782K	1.56M
Imputed Operating Lease Depreciation	1.4M	1.46M	1.56M	2.6M	2.18M
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	23.56M	7.5M
Total Stock-Based Compensation	-	-	-	23.56M	7.5M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Assets
Cash And Equivalents	1.5B	1.24B	711M	482M	396M
Trading Asset Securities, Total	-	50.56M	-	30M	534M
Total Cash And Short Term Investments	1.5B	1.29B	711M	512M	930M
Accounts Receivable, Total	236M	237M	208M	129M	128M
Other Receivables	82.85M	36.53M	26.65M	18.87M	23.73M
Total Receivables	318M	273M	234M	147M	152M
Inventory	352M	214M	191M	189M	206M
Other Current Assets, Total	34.17M	40.4M	18.19M	29.06M	30.81M
Total Current Assets	2.2B	1.82B	1.15B	877M	1.32B
Gross Property Plant And Equipment	2.13B	2.07B	2.06B	2.05B	2.05B
Accumulated Depreciation	-892M	-949M	-998M	-1.02B	-1.06B
Net Property Plant And Equipment	1.24B	1.12B	1.06B	1.03B	986M
Long-term Investments	498M	458M	298M	278M	238M
Goodwill	411M	369M	369M	369M	369M
Other Intangibles, Total	290M	221M	191M	167M	163M
Deferred Tax Assets Long-Term	24.19M	33.77M	21.01M	16.46M	16.53M
Deferred Charges Long-Term	17.21M	9.7M	8.23M	14.45M	7.97M
Other Long-Term Assets, Total	18.21M	46.62M	51.58M	74.73M	36.2M
Total Assets	4.7B	4.07B	3.15B	2.83B	3.13B
Liabilities
Accounts Payable, Total	270M	75.48M	69.88M	60.45M	65.13M
Accrued Expenses, Total	527M	517M	431M	86.51M	342M
Short-term Borrowings	1.56B	1.45B	676M	-	90.06M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	-	-	-	1.33M	1.38M
Current Income Taxes Payable	9.33M	10.26M	9.67M	10.23M	7.71M
Unearned Revenue Current, Total	86.98M	83.17M	50.03M	44.2M	44.9M
Other Current Liabilities	226M	195M	176M	620M	247M
Total Current Liabilities	2.68B	2.34B	1.41B	823M	798M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	-	-	1.95M	566K
Unearned Revenue Non Current	24.53M	21.43M	17.87M	12.92M	12.32M
Deferred Tax Liability Non Current	12.55M	12.87M	12.12M	13.28M	13.19M
Other Non Current Liabilities	825K	27.62K	-	1.08M	1.08M
Total Liabilities	2.72B	2.37B	1.44B	852M	825M
Common Stock, Total	2.2B	2.2B	2.2B	2.28B	2.23B
Additional Paid In Capital	448M	471M	380M	457M	413M
Retained Earnings	-743M	-1.03B	-914M	-681M	-305M
Treasury Stock	-	-	-	-102M	-42.93M
Comprehensive Income and Other	-9.61M	-4.17M	-3.32M	-3.09M	-4.19M
Total Common Equity	1.89B	1.63B	1.66B	1.95B	2.29B
Minority Interest	84.7M	72.3M	48.46M	22.15M	15.9M
Total Equity	1.98B	1.7B	1.71B	1.97B	2.31B
Total Liabilities And Equity	4.7B	4.07B	3.15B	2.83B	3.13B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.2B	2.2B	2.2B	2.28B	2.23B
ECS Total Common Shares Outstanding	2.2B	2.2B	2.2B	2.28B	2.23B
Book Value / Share	0.86	0.74	0.76	0.86	1.03
Tangible Book Value	1.19B	1.04B	1.1B	1.42B	1.76B
Tangible Book Value Per Share	0.54	0.47	0.5	0.62	0.79
Total Debt	1.56B	1.45B	676M	3.28M	92.01M
Net Debt	62.42M	167M	-35.59M	-509M	-838M
Debt Equivalent Oper. Leases	18.42M	18.42M	18.42M	27.02M	29.89M
Minority Interest, Total (Incl. Fin. Div)	84.7M	72.3M	48.46M	22.15M	15.9M
Equity Method Investments, Total	295M	282M	68.54M	68.29M	67.03M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	111M	77.32M	78.35M	60.25M	74.36M
Inventories - Work In Process, Total	96.84M	90.08M	70.45M	49.99M	54.93M
Inventories - Finished Goods, Total	208M	128M	119M	124M	104M
Buildings, Total	1.31B	1.24B	1.23B	1.23B	1.24B
Machinery, Total	802M	803M	808M	797M	794M
Full Time Employees	4.77K	3.51K	3.08K	2.7K	2.35K
Accumulated Allowance for Doubtful Accounts (Supple)	9.57M	1.25M	1.04M	641K	661K

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Net Income	45.04M	-291M	120M	233M	377M
Depreciation & Amortization - CF	104M	91.95M	74.07M	61.47M	56.96M
Amortization of Goodwill and Intangible Assets - (CF)	39.13M	36.94M	29.51M	29.84M	33.28M
Depreciation & Amortization, Total	143M	129M	104M	91.31M	90.24M
Amortization of Deferred Charges, Total - (CF)	7.08M	6.82M	5.99M	654K	553K
(Gain) Loss From Sale Of Asset	-4.65M	-3.82M	-2.84M	-3.4M	-3.54M
(Gain) Loss on Sale of Investments - (CF)	9.31M	270M	41.37M	8.73M	-143M
Asset Writedown & Restructuring Costs	1.84M	79.45M	283K	3.53M	8.88M
Provision for Credit Losses	-	-	-	-	-
Provision and Write-off of Bad Debts	-529K	-313K	-208K	-403K	101K
Other Operating Activities, Total	96.45M	97.17M	58.95M	18.93M	11.56M
Change In Accounts Receivable	134M	55.14M	63.57M	77.65M	-6.63M
Change In Inventories	22.09M	120M	35.44M	-31.04M	-19.22M
Change In Accounts Payable	-184M	-191M	-97.86M	-17.05M	-50.33M
Change In Deferred Taxes	4.58M	-9.26M	12.01M	5.71M	-160K
Change in Other Net Operating Assets	-	-	-66.44M	23.56M	7.5M
Cash from Operations	274M	262M	274M	411M	273M
Capital Expenditure	-34.51M	-33.01M	-29.62M	-62.9M	-23.81M
Sale of Property, Plant, and Equipment	3.04M	40.05M	13.65M	18.73M	11.42M
Cash Acquisitions	-	-	-	-2.66M	-299K
Divestitures	74.92M	2.88M	732K	-	-
Investment in Marketable and Equity Securities, Total	31.66M	-250M	103M	-24M	-361M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	6.15M	16.2M	6.61M	11.97M	41.48M
Cash from Investing	81.26M	-224M	94.38M	-58.86M	-332M
Short Term Debt Issued, Total	1.95B	1.56B	1.1B	115M	90M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	1.95B	1.56B	1.1B	115M	90M
Short Term Debt Repaid, Total	-1.67B	-1.66B	-	-790M	-
Long-Term Debt Repaid, Total	-	-	-1.87B	-1.05M	-1.5M
Total Debt Repaid	-1.67B	-1.66B	-1.87B	-791M	-1.5M
Issuance of Common Stock	-	-	-	103M	-
Repurchase of Common Stock	-	-	-	-1.19M	-99.72M
Common Dividends Paid	-70.94M	-68.76M	-43.81M	-9.36M	-1.21M
Common & Preferred Stock Dividends Paid	-70.94M	-68.76M	-43.81M	-9.36M	-1.21M
Other Financing Activities, Total	157M	-40.77M	-67.22M	-	-11.62M
Cash from Financing	362M	-213M	-889M	-583M	-24.05M
Foreign Exchange Rate Adjustments	-1.57M	11.92M	987K	939K	-1.89M
Net Change in Cash	715M	-163M	-520M	-230M	-84.94M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	281M	288M	266M	255M	240M
Levered Free Cash Flow	260M	51.24M	101M	351M	78.31M
Unlevered Free Cash Flow	305M	94.16M	127M	358M	79.86M
Change In Net Working Capital	-117M	62.04M	60.08M	-164M	139M
Net Debt Issued / Repaid	275M	-103M	-778M	-676M	88.5M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Profitability
Return on Assets	1.57	1.22	2.97	4.71	4.84
Return on Total Capital	2.12	1.6	3.88	6.46	6.59
Return On Equity %	2.75	-15.72	7.54	13.17	17.86
Return on Common Equity	2.41	-16.53	7.31	12.89	17.76
Margin Analysis
Gross Profit Margin %	73.52	76.1	58.27	53.4	45.25
SG&A Margin	65.44	68.79	47.36	39.31	29.41
EBITDA Margin %	8.05	6.9	10.49	12.94	14.97
EBITA Margin %	4.92	3.94	7.67	10.45	12.36
EBIT Margin %	3.68	2.75	6.55	9.23	10.81
Income From Continuing Operations Margin %	1.71	-9.32	4.9	9.94	17.91
Net Income Margin %	1.43	-9.37	4.58	9.54	17.65
Net Avail. For Common Margin %	1.43	-9.37	4.58	9.54	17.65
Normalized Net Income Margin	0.58	0.89	3.07	5.56	10.51
Levered Free Cash Flow Margin	8.28	1.65	3.83	14.4	3.67
Unlevered Free Cash Flow Margin	9.7	3.03	4.85	14.65	3.74
Asset Turnover
Asset Turnover	0.68	0.71	0.73	0.82	0.72
Fixed Assets Turnover	2.44	2.64	2.41	2.34	2.12
Receivables Turnover (Average Receivables)	10.89	13.14	11.78	14.49	16.58
Inventory Turnover (Average Inventory)	2.3	2.62	5.41	6	5.93
Short Term Liquidity
Current Ratio	0.82	0.78	0.82	1.07	1.65
Quick Ratio	0.68	0.67	0.67	0.8	1.36
Operating Cash Flow to Current Liabilities	0.1	0.11	0.19	0.5	0.34
Days Sales Outstanding (Average Receivables)	33.52	27.79	30.97	25.27	22.01
Days Outstanding Inventory (Average Inventory)	158.42	139.14	67.41	61.03	61.59
Average Days Payable Outstanding	124.39	104.41	24.74	21	19.32
Cash Conversion Cycle (Average Days)	67.56	62.52	73.65	65.3	64.28
Long Term Solvency
Total Debt/Equity	78.74	85.41	39.51	0.17	3.98
Total Debt / Total Capital	44.05	46.07	28.32	0.17	3.83
LT Debt/Equity	-	-	-	0.1	0.02
Long-Term Debt / Total Capital	-	-	-	0.1	0.02
Total Liabilities / Total Assets	57.85	58.19	45.75	30.17	26.32
EBIT / Interest Expense	1.62	1.25	4.03	22.95	93.04
EBITDA / Interest Expense	3.62	3.12	6.46	32.24	129.42
(EBITDA - Capex) / Interest Expense	3.14	2.64	5.77	25.84	119.82
Total Debt / EBITDA	6.02	6.78	2.45	0.01	0.29
Net Debt / EBITDA	0.24	0.78	-0.13	-1.61	-2.61
Total Debt / (EBITDA - Capex)	6.95	8.02	2.75	0.01	0.31
Net Debt / (EBITDA - Capex)	0.28	0.92	-0.14	-2	-2.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.96	-1.19	-15.51	-7.06	-12.51
Gross Profit, 1 Yr. Growth %	4.9	2.29	-12.35	-14.82	-25.86
EBITDA, 1 Yr. Growth %	5.57K	-15.77	27.77	14.34	0.96
EBITA, 1 Yr. Growth %	-255.94	-21.55	62.87	26.15	3.22
EBIT, 1 Yr. Growth %	-179.94	-25.99	100.88	31.04	2.42
Earnings From Cont. Operations, 1 Yr. Growth %	-86.83	-637.77	-144.45	88.45	57.65
Net Income, 1 Yr. Growth %	-88.74	-746.79	-141.31	93.43	61.93
Normalized Net Income, 1 Yr. Growth %	-94.69	50.41	192.28	68.08	65.45
Diluted EPS Before Extra, 1 Yr. Growth %	-88.74	-746.34	-141.28	88.12	63.85
Accounts Receivable, 1 Yr. Growth %	-30.62	0.52	-12.31	-38.06	-0.19
Inventory, 1 Yr. Growth %	-5.09	-39.18	-10.96	-1.05	9.12
Net Property, Plant and Equip., 1 Yr. Growth %	-7.8	-9.38	-5.43	-2.8	-4.23
Total Assets, 1 Yr. Growth %	3.96	-13.23	-22.62	-10.38	10.95
Tangible Book Value, 1 Yr. Growth %	9.93	-12.72	5.8	28.47	24.5
Common Equity, 1 Yr. Growth %	2.6	-13.88	1.87	17.39	17.58
Cash From Operations, 1 Yr. Growth %	2.05K	-4.58	4.8	49.88	-33.48
Capital Expenditures, 1 Yr. Growth %	-20.96	-4.34	-10.27	112.33	-62.14
Levered Free Cash Flow, 1 Yr. Growth %	130.78	-80.32	96.5	252.92	-77.72
Unlevered Free Cash Flow, 1 Yr. Growth %	81.4	-69.13	35.25	183.26	-77.67
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-21.11	0.86	-8.63	-11.38	-9.82
Gross Profit, 2 Yr. CAGR %	-21.06	3.58	-18.65	-13.6	-20.53
EBITDA, 2 Yr. CAGR %	-34.91	592.93	4.02	21.04	7.55
EBITA, 2 Yr. CAGR %	-43.15	11.11	13.57	43.62	14.26
EBIT, 2 Yr. CAGR %	-47.28	-23.08	21.93	62.23	15.85
Earnings From Cont. Operations, 2 Yr. CAGR %	-85.76	-15.83	54.61	-8.47	72.36
Net Income, 2 Yr. CAGR %	-86.99	-14.66	63.45	-10.62	76.98
Normalized Net Income, 2 Yr. CAGR %	-34.76	-71.74	109.67	121.63	66.76
Diluted EPS Before Extra, 2 Yr. CAGR %	-86.99	-14.68	63.35	-11.87	75.56
Accounts Receivable, 2 Yr. CAGR %	-32.6	-16.49	-6.11	-26.3	-21.38
Inventory, 2 Yr. CAGR %	-12.09	-24.02	-26.41	-6.13	3.91
Net Property, Plant and Equip., 2 Yr. CAGR %	-9.3	-8.59	-7.43	-4.12	-3.51
Total Assets, 2 Yr. CAGR %	-14.4	-5.02	-18.06	-16.73	-0.28
Tangible Book Value, 2 Yr. CAGR %	31.3	-2.05	-3.9	16.59	26.47
Common Equity, 2 Yr. CAGR %	11.58	-6	-6.34	9.35	17.48
Cash From Operations, 2 Yr. CAGR %	-32.98	352.73	-0	25.33	-0.15
Capital Expenditures, 2 Yr. CAGR %	-15.58	-13.05	-7.36	38.03	-10.34
Levered Free Cash Flow, 2 Yr. CAGR %	40.39	-32.61	-37.81	161.91	-11.33
Unlevered Free Cash Flow, 2 Yr. CAGR %	16.87	-25.17	-35.39	94.89	-20.47
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-16.9	-14.96	-4.92	-8.11	-11.76
Gross Profit, 3 Yr. CAGR %	-17.24	-13.94	-11.46	-17.4	-17.89
EBITDA, 3 Yr. CAGR %	-28.32	-28.93	295.11	7.46	14.02
EBITA, 3 Yr. CAGR %	-35.26	-36.52	26.61	17.77	28.75
EBIT, 3 Yr. CAGR %	-38.75	-40.97	5.93	24.89	39.17
Earnings From Cont. Operations, 3 Yr. CAGR %	-25.23	-52.22	-31.96	65.16	9.71
Net Income, 3 Yr. CAGR %	-29.01	-52.17	-33	72.89	8.96
Normalized Net Income, 3 Yr. CAGR %	-55.11	-13.82	-38.42	94.77	101.05
Diluted EPS Before Extra, 3 Yr. CAGR %	-29.01	-52.17	-33.02	71.22	8.36
Accounts Receivable, 3 Yr. CAGR %	-32.26	-22.99	-15.12	-18.27	-18.46
Inventory, 3 Yr. CAGR %	-7.6	-22.25	-19.9	-18.78	-1.3
Net Property, Plant and Equip., 3 Yr. CAGR %	-10.46	-9.32	-7.55	-5.91	-4.16
Total Assets, 3 Yr. CAGR %	-20.87	-14.01	-11.29	-15.58	-8.37
Tangible Book Value, 3 Yr. CAGR %	41.69	14.59	0.5	5.86	19.17
Common Equity, 3 Yr. CAGR %	-24.05	2.35	-3.45	0.98	12.03
Cash From Operations, 3 Yr. CAGR %	-38.22	-24.6	177.98	14.44	1.47
Capital Expenditures, 3 Yr. CAGR %	-30.84	-11.99	-12.13	22.15	-10.32
Levered Free Cash Flow, 3 Yr. CAGR %	-24.59	-27.07	-3.72	10.52	15.19
Unlevered Free Cash Flow, 3 Yr. CAGR %	-24.6	-25.02	-8.85	5.45	-5.34
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.06	0.43	-13.69	-13.55	-6.91
Gross Profit, 5 Yr. CAGR %	5.8	1.99	-17.81	-18.88	-15.21
EBITDA, 5 Yr. CAGR %	-25.12	-21.2	-16.71	-11.97	134.92
EBITA, 5 Yr. CAGR %	-30.66	-26.91	-18.79	-11.84	21.61
EBIT, 5 Yr. CAGR %	-33.96	-30.55	-19.33	-11.55	9.79
Earnings From Cont. Operations, 5 Yr. CAGR %	-40.61	-1.05	-0.01	-38.04	-1.32
Net Income, 5 Yr. CAGR %	-42.5	-1.21	-0.9	-38.57	-1.18
Normalized Net Income, 5 Yr. CAGR %	-48.51	-36.11	-16.84	25.75	-8.28
Diluted EPS Before Extra, 5 Yr. CAGR %	-42.49	-1.22	-0.92	-38.93	-1.52
Accounts Receivable, 5 Yr. CAGR %	-0.67	-11.93	-22.82	-24.33	-17.68
Inventory, 5 Yr. CAGR %	5.36	-14.52	-15.64	-16.17	-11.11
Net Property, Plant and Equip., 5 Yr. CAGR %	-7.41	-8.84	-9.26	-7.28	-5.96
Total Assets, 5 Yr. CAGR %	-11.54	-14.78	-19.76	-15.11	-7.04
Tangible Book Value, 5 Yr. CAGR %	52.82	66.93	21.31	15.39	10.18
Common Equity, 5 Yr. CAGR %	-13.73	-17.13	-17.41	5.1	4.44
Cash From Operations, 5 Yr. CAGR %	-23.41	-16.69	-25.1	-7.61	84.56
Capital Expenditures, 5 Yr. CAGR %	-28.55	-29.87	-22.26	5.37	-11.42
Levered Free Cash Flow, 5 Yr. CAGR %	50.02	-39.42	-30.19	21.62	-7.04
Unlevered Free Cash Flow, 5 Yr. CAGR %	24.41	-29.05	-29.12	9.87	-13.84
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	-